CJ announces license agreement with Helsinn
Published: 2012-09-26 06:56:00
Updated: 2012-09-26 06:56:00
CJ CheilJedang said last Monday that it has signed a license agreement with Switzerland based Helsinn Healthcare SA for Helsinn’s new product for potential use in the prevention of chemotherapy-induced nausea and vomiting (CINV).
According to CJ officials, the agreement covers the exclusive li...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
